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Abstract
One of the limitations of anatomical based imaging approaches is its relative inability to identify
whether specific brain functions may be compromised by the location of brain lesions or
contemplated brain surgeries. For this reason, methods for identifying the regions of eloquent
brain that should not be disturbed are absolutely critical to the surgeon. By accurately identifying
these regions preoperatively, virtually every pre-surgical decision from the surgical approach,
operative goals (biopsy, sub-total vs. gross-total resection), and the potential need for awake
craniotomy with intraoperative cortical-mapping is affected. Of the many techniques available to
the surgeon, functional magnetic resonance imaging (fMRI) has become the primary modality of
choice due to the ability of MRI to serve as a “one-stop shop” for assessing both anatomy and
functionality of the brain. Given their prevalence, brain tumors serve as the model pathology for
the included discussion; however, a similar case can be made for the use of fMRI in other
neurological conditions, most notably epilepsy. The value of fMRI was validated in 2007 when
the Centers for Medicare and Medicaid Services (CMS) established three new current procedural
terminology (CPT) codes for clinical fMRI based upon its use for pre-therapeutic planning. In this
article we will discuss the specific requirements for establishing an fMRI program, including
specific software and hardware requirements. In addition, the nature of the fMRI CPT codes will
be discussed.
Background
From the discovery of the Roentgen Ray over a century ago, the primary focus of radiology
has been the non-invasive demonstration of structural anatomy of the human body. Through
the demonstration of alteration of normal anatomy, the identification of pathology was
elicited. The wide availability of cross sectional imaging modalities, first with computed
tomography (CT) followed by magnetic resonance imaging (MRI), resulted in marked
improvements in the quality of the depiction of anatomical structures in three-dimensional
space. The anatomical region most impacted by these techniques was the neuraxis, which
had been previously hidden by the calvarium and vertebral column.
As this issue of the Clinics demonstrates, a new focus on physiologic imaging has developed
over the past two decades. Through these methods, the imaging aim has shifted from the
demonstration of anatomy to the evaluation of physiology. Many of these so-called
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“functional imaging” approaches are being refined, including the imaging of blood flow
(perfusion), specific metabolites (spectroscopy) and regional blood oxygenation (Blood
Oxygen Level Dependent, or BOLD imaging.) Taken as a whole, each of these methods can
be considered functional imaging, although the aim of this article is to describe approaches
involving BOLD imaging.
As more completely described elsewhere in this issue, BOLD imaging is based on a
phenomenon first described by Roy and Sherrington in Cambridge in 1890 demonstrating
that neural activation induced increased blood flow in the blood vessels supplying and
draining that area of cerebral cortex (24). This phenomenon remained unexploited for nearly
a century until the development of Positron Emission Tomography (PET) imaging in the
1980’s. The phenomenon was further leveraged with the development of BOLD functional
magnetic resonance imaging (fMRI) in 1990 (19). The power of the BOLD method was
made evident in early studies when regions of brain activation associated with various
motor, sensory, visual and language tasks were mapped in normal subjects (12). This was
followed by the development of paradigms used to evaluate pathologic states including brain
tumors, multiple sclerosis, strokes, epilepsy and Alzheimer’s disease.
The fMRI technique remained largely a research modality until 2007 when the Centers for
Medicare and Medicaid Services (CMS) issued three separate current procedural
terminology (CPT) codes for its clinical use (Table I). The recommendation for the
development of CPT codes was based largely upon experience at major academic medical
centers that had begun to use fMRI as a presurgical technique for mapping eloquent regions
of the brain, typically under the auspices of an institutional review board (IRB) approved
protocol. Using this approach, the typical study consisted of developing fMRI paradigms for
the identification of motor areas, speech centers, and sensory regions that should be avoided
by the surgeon during a craniotomy. This development of clinical CPT codes has led to
significantly increased interest in the use of fMRI by clinicians and consequent increases in
the number of studies ordered in many institutions. The aim of this short article is to
describe both the rationale for establishing a clinical fMRI service and the basic
requirements for hardware and software. In addition, there is a short discussion on the
implementation of the CPT codes.
I. Rationale for establishing an fMRI Center in support of Brain Tumor
Centers
According to the Brain Tumor Society, there are in excess of 200,000 newly diagnosed brain
tumors (primary or metastatic) each year within the United States. Despite significant
advances in both chemotherapy and radiation treatments, neurosurgery remains the
preeminent treatment modality in most cases. Numerous outcomes of gross-total resection of
a brain tumor include: relief of mass effect, decreased risk of epilepsy, increased time to
tumor progression, and increased survival (1, 2, 21). However, the pre-operative goal of
gross total resection can be thwarted intraoperatively by the difficulty in determining tumor
boundaries. This is particularly true for infiltrating gliomas which may be difficult to
distinguish from healthy brain due to indistinct, infiltrative margins with healthy brain
parenchyma. Moreover, the proximity of tumor to eloquent brain carries the risk of
functional loss following surgery if those regions are violated. By mapping the boundaries
of eloquent brain in the context of tumor-distorted anatomy, neurofunctional testing
approaches have been used over the past quarter century to improve surgical outcomes.
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Functional Imaging
Functional MRI is a non-invasive MR-based brain mapping technique that requires no
exogenous contrast agents. Through the investment in a minimal amount of hardware and
software that can be obtained at incremental cost, fMRI can be added to most existing MR
scanners. Evaluation of multiple functions is feasible in patients with cerebral tumors using
fMRI (16), and pre-operative maps depicting brain areas activated during motor, sensory,
and language tasks can be obtained using task paradigms specific to the function or
functions of interest. Typical paradigms include motor mapping (e.g. hand clenching, finger
tapping, toe movement), language (word generation, sentence completion and similar tasks)
and visual stimulation (typically a flashing checkerboard or annulus). The resulting maps are
useful for pre-surgical planning and can be integrated into neuronavigation systems to guide
intra-operative decision-making (6, 7, 10, 11, 13, 14, 17, 18, 22, 23) (Figure 1). Strong
evidence that a more radical tumor resection may be achieved by using fMRI information
during neurosurgery has been demonstrated by Krishnan et al. (2004) and Haberg et al.
(2004) (8, 11). Diffusion tensor imaging (DTI) based tractography has recently emerged as
another potentially valuable tool to visualize white matter anatomy for pre-operative
planning (3, 5, 9, 15, 27–29) and postoperative follow-up (4) of surgically treated brain
tumors and vascular malformations (Figure 2). In addition, the use of fMRI has been shown
to significantly reduce operative time and facilitate pre-operative decision making as to
whether to perform surgeries awake or under general anesthesia (20).
II. Software and Hardware Requirements
Although most mid- and high-field MRI scanners in clinical use are capable of performing
functional magnetic resonance imaging, most will require upgrades of scanner software and
hardware to perform the imaging. In addition, software “keys” for specialized pulse
sequences required for performing fMRI on the MRI scanner, such as BOLD or diffusion
tensor imaging (DTI) echo planar sequences, may be required. Specialized software is
required both for administering the test and for interpreting the test results properly. These
will be discussed separately below. There is also a specific need for specially trained
individuals to administer and interpret the test.
Stimulus Delivery Software and Hardware
The specialized software required for performing the study is known as stimulus delivery
software. This software handles several tasks that are not part of standard MRI studies.
Specifically, the software must do three things: (i) synchronize with the MRI scanner
software to initiate the proper pulse sequences to be performed by the scanner at the
appropriate time, (ii) provide the appropriate stimulus to the subject to activate the brain area
of interest at the proper time, and (iii) record any associated data such as feedback from
response devices at the appropriate times. To perform these tasks, there are many solutions,
offered by both the original equipment manufacturers (OEMs) as well as by third parties.
The ability to synchronize with the native scanner software to perform the appropriate pulse
sequence is central to the fMRI experiment. The synchronization is critical because precise
knowledge of the task timing relative to image acquisition is required to tease out the small
signal differences between task and control conditions. When utilizing OEM stimulus
software, it may reside on the scanner console itself. In contrast, when using third party
stimulus software, it typically resides on another computer that is linked to the scanner
computer, usually through a specialized hardware synchronization device (figure 3).
There are several different stimulus devices that are available that may need to be powered
by the stimulus software. In many instances, visual stimuli are provided to the subject. As
such, several different kinds of visual display devices may potentially be used. Typically a
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video projector or special MRI compatible eye goggles are used to display a visual stimulus
at appropriate times to the subject (figure 3). More recently, several vendors have developed
MRI-compatible high definition liquid crystal display (HD-LCD) monitors. In fact, the
development of the HD-LCD monitors has necessitated computer hardware upgrades as
older systems do not have the high-definition video output that is capable of supporting the
HD-LCD monitors. Alternatively, auditory stimuli are commonly used and delivered
through non-magnetic headsets or ear buds, and high quality audio-systems are also
available for auditory stimulus presentation,. The third component of the stimulus delivery
software is the ability to record behavioral data and subject response data at the proper time
point. The types of data recorded can be from a variety of devices, such as button boxes and
eye tracking cameras (figure 3).
Analysis Software
Analysis software generates the work-product of the entire process. To be useful, the
analysis software must be able to accept both BOLD datasets and high resolution anatomical
datasets. In the current day, analysis software will typically accept other types of data
including perfusion, DTI and angiographic datasets. In almost all instances, the analysis
software packages are run on a post-processing workstation, whether the software has been
provided by the OEM or not. The analysis software performs two main tasks: (i) data
reduction, and (ii) data display. Software subroutines that are useful for the analysis of each
of these datasets frequently include BOLD data, DTI data, and high-resolution anatomical
data. It should be noted that the typical fMRI experiment generates thousands of images, and
that a separate data transfer protocol from the scanner to the post processing station is
usually required. The images then need to be appropriately grouped according to the analytic
module and statistically analyzed. Activations are then identified based upon a user defined
threshold and displayed as a 3D map that is superimposed upon the anatomical images.
Typically, it possible to both modify the data in real time and to cut planes and rotate
projections viewed in the 3D and orthogonal view displays. More advanced systems allow
one to display activations from multiple task paradigms simultaneously and toggle them on
and off (Figure 4).
For archival purposes, a threshold level is chosen by the user and then orthogonal views are
output in digital imaging and communications in medicine (DICOM) format for loading into
institutional picture archiving and communication systems (PACS). Surgeons also
appreciate the ability to export the processed fMRI data to neuronavigation systems for use
intraoperatively, and this function is now frequently offered in commercial packages, though
data transfer work-arounds used to be necessary. Given the significant impact that these
software packages have in clinical decision making, many vendors have obtained approval
by the Food and Drug Administration (FDA) for their clinical software packages.
Scanner Hardware Requirements
The main hardware requirement obviously is a mid or high-field MRI scanner (1.5–3.0 Tesla
(T)). There is improved signal observed at higher magnetic field strengths such that fMRI
performed at 3 T MRI is of significantly higher quality than at 1.5 T. (25, 26). Echo planar
imaging is typically used for fMRI, and as such, the scanner gradient coils must be capable
of rapidly switching gradients. A multichannel head coil will also provide improved signal
acquisition over a single channel coil. The scanner should be approved for fMRI use prior to
implementing a program, and the pulse sequences should then be assessed according to
routine quality control guidelines by the institutional MRI physicist.
Retrofitting of an existing MRI scanner to perform fMRI will require physical modifications
to the scanner room. The specific hardware required for fMRI stimulus presentation will
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need to be installed. Devices for visual display include eye-goggles, projectors, or MRI
compatible LCD panels; audio devices include headphones or ear buds, as described above.
Frequently, optical cables are used to transfer the signals from the control room to the
scanner room through a device known as a waveguide. Access to the scanning room via a
penetration panel may also be necessary for other instrumentation, such as physiological
recording equipment. In addition, appropriate mounts for cameras and LCD panels may
need to be installed. Once the system is set up, several test runs with control subjects should
be performed, to test all components, and train personnel.
Personnel and Training
Personnel administering the fMRI exam need specific training to use the fMRI hardware and
software, as well as on methodological issues related to the functional tasks. In many cases
the exams will be performed by technologists, and often the equipment/software
manufacturer will provide on site training. The visual display devices must be set up to
demonstrate clear images to the subject that are observed by both eyes and can stimulate all
of the visual fields. Therefore, goggles are often adjustable to for the interophthalmic
distance and requisite visual corrections as needed for each subject. Similarly, projectors or
LCD monitors must be positioned such that the subjects can properly see them. When
setting up the audio system, care must be taken to insure that the subjects can adequately
hear the presented content independently in each ear while the scanner is running.
Additionally, prior to scanning, the technologist will need to instruct the patient and assist
with practicing the behavioral task paradigms that will be run. This is crucial to assure that
the tasks are performed correctly, so that the functions of interest can be assessed. Patients
that are aphasic or have motor deficits may require additional coaching. Ensuring patient
comfort and reducing head motion with appropriate padding are paramount, as both factors
can affect task performance. Task performance should also be monitored during the
scanning session to ensure the task paradigms are followed. After the scan, the data will
need to be analyzed by the technologist or additional trained personnel.
The American College of Radiology in collaboration with the American Society of
Neuroradiology published guidelines for performing fMRI studies in 2007. In these
guidelines, the physician supervising and interpreting fMRI is tasked with being clinically
informed about the patient and understanding the “specific questions to be answered prior to
the procedure in order to plan and perform it safely and effectively.” The physician should
also have experience or formal training in the performance of fMRI.
As with any MRI study, the supervising physician must understand indications, risks, and
benefits of the examination, as well as the alternative imaging procedures such as a Wada
test. Risk assessment involves knowledge of patient factors, including the presence of a
pacemaker or other medical device that is potentially hazardous in the MR environment. An
understanding of the hazards of MRI contrast encompassing both allergies and the potential
of nephrogenic systemic fibrosis in the setting of significant renal impairment is critical if
contrast administration is being considered.
The physician interpreting the study should be familiar with the patient’s clinical
presentation, relevant prior history, and imaging studies. Obviously, the physician
performing the fMRI interpretation must also have appropriate knowledge and
understanding of the anatomy and pathophysiology in order to render a meaningful
interpretation. Experience with fMRI paradigm design, selection, administration and
validation is also critical to rendering a quality interpretation. Rigorous quality assessment
of every study should take into account factors such as patient compliance with the protocol
and patient motion. Confounding issues such as magnetic susceptibility artifact at the
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skullbase or due to the presence of blood-products or metal is essential to performing high
quality interpretation. Finally the interpreting physician must understand the BOLD effect
and potential sources of neurovascular uncoupling that could cause false negative
activations.
III. CPT Codes
In the Current Procedural Terminology (CPT) code book in 2007, three new CPT codes
were added for functional MRI. (Table 1) The codes can be separated into two main
categories: (i) simple paradigms that are performed by a technologist (70554), and (ii)
complex paradigms that are administered by a physician or neuropsychologist (70555 +
96020). One example of the 70554 code would be simple motor paradigms performed by a
technologist without input from a physician to map motor activations. When using the
second code, there are many specific criteria that must be met including the need to perform
at least two fMRI paradigms with one of the tests being designed to identify higher cognitive
function running the gamut from memory and attention tasks to language to executive
functioning. Moreover, the physician or psychologist is expected to select the test,
demonstrate the test to the subject, administer the test, interpret the results and consult with
the referring physician. After this is performed, the 70555 code is billed to report the fMRI
portion of the study and 96020 is used to report on the neurocognitive testing. It should be
noted that standard neurocognitive testing should not be performed on the same day as
functional MRI. Similarly, it is the belief of the American Medical Association, which
manages the CPT coding system, that standard MRI is usually not performed on the same
day as the fMRI study. If such a study is to be performed on the same day as the fMRI, a
separate order is required for each study and a special modifier code is used to demonstrate
that MRI brain evaluation beyond the fMRI was also performed.
As with most MRI examinations, many third-party payers require that the site performing
the fMRI be accredited. The main accrediting bodies in the United States include the
American College of Radiology (ACR), Joint Commission on Accreditation of Healthcare
Organizations (JCAHO), Accreditation Association for Ambulatory Health Care (AAAHC/
Accreditation Association) and the Intersocietal Commission for the Accreditation of
Magnetic Resonance Laboratories (ICAMRL). Although varying by agency, the
accreditation process is comprehensive. For example, the ACR requires that sites submit
deidentified images obtained from actual patient studies for quality evaluation by central
readers. In addition, there are specified phantom studies that also need to be submitted.
IV. Position of Professional Societies
Several imaging-based professional societies have adopted positions in support of the
development of clinical fMRI programs. These are summarized below. Currently, the
American Association of Neurological Surgeons (AANS) and the Congress of Neurological
Surgeons (CNS) do not have any official policy, while the American Academy of Neurology
(AAN) and the American Society of Functional Neuroradiology are presently conducting
systematic reviews of the literature and developing clinical fMRI guidelines.
Radiological Society of North America (RSNA) Position
According to the RSNA (2007), fMRI is becoming the diagnostic method of choice for
learning how a normal, diseased or injured brain is working, as well as for assessing the
potential risks of surgery or other invasive treatments of the brain. Physicians perform fMRI
to:
• examine the anatomy of the brain.
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• determine precisely which part of the brain is handling critical functions such as
thought, speech, movement and sensation, which is called brain mapping.
• help assess the effects of stroke, trauma or degenerative disease (such as
Alzheimer's) on brain function.
• monitor the growth and function of brain tumors.
• guide the planning of surgery, radiation therapy, or other surgical treatments for the
brain.
American College of Radiology (ACR) Position
In the October 2007 ACR published a new Practice Guideline “for the Performance of
Functional Magnetic Resonance Imaging of the Brain (fMRI)” October 2007. The ACR
states that BOLD fMRI is an appropriate method for evaluation of eloquent cortex in
relation to focal brain lesions. Typically, either neoplasm or vascular malformation is the
suspected lesion.
Primary indications for fMRI include:
A. Assessment of Intracranial Tumoral Disease
1. Presurgical planning, Assessment of eloquent cortex (e.g., language,
sensory motor, visual) in relation to a tumor.
2. Surgical planning (biopsy or resection), Use of fMRI data for surgical
guidance or resection procedure.
3. Therapeutic follow-up, Evaluation of preserved eloquent cortex.
B. Assessment of Language Functions for Epilepsy Surgery
In fact this support by professional organizations combined with the wealth of developing
literature led to CMS approving CPT codes for fMRI based upon clinical indications
summarized above.
V. Summary
The growing body of evidence demonstrating the utility of fMRI as a means for presurgical
evaluation led to the development of CPT codes for performing clinical fMRI examinations.
This has been followed by an increased demand in the number of studies ordered.
Structurally, a clinical fMRI service can be established by adding additional hardware and
software components to most existing mid- and high-field examinations. There is also a
need for specific training for the personnel who will be performing and interpreting the
exams.
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Figure 1.
An Example of intra-operative display of BOLD data. The tumor volume is segmented in
green, language task BOLD activations are displayed in pink, and DTI based fiber
tractography is displayed in yellow.
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Figure 2.
DTI tractography (tubes) displayed with the segmented tumor volume (transparent green),
and a proximal fMRI activation. The red sphere is the tract seed point.
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Figure 3.
Examples hardware used to perform fMRI. A goggle system used to display stimuli during
an exam (a), a synchronization box used to synch the paradigm and scanner (b), and input
devices for response recording (c) and (d).
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Figure 4.
An example of thresholded data used for presurgical planning from both a hand clenching
task (red, t=5.31) and a finger tapping task (green, t= 7.35).
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Table 1
Summary of the current procedural terminology codes (CPT codes) for fMRI.
CPT Code Description
70554 Functional MRI selected and performed by a technologist.
Do not report with CPT 96020, or CPT 70555.
70555 Complex paradigms for fMRI selected and performed by a physician or psychologist, involving neurofunctional testing.
Report with CPT 96020.
96020 Neurofunctional testing by physician or psychologist, with review of results and report.
Report with CPT 70555.
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